Diary - News All news MaaT Pharma Presents Product Analysis

MaaT Pharma Presents Product Analysis

MaaT Pharma Presents Product Analysis of its First-in-class High Diversity Microbiome Therapeutic at 2018 EMBO Symposium on The Human Microbiome

Results from in silico analysis using MaaT Pharma’s data analysis platform, GutPrint, demonstrate therapeutic rationale and manufacturing capabilities of developing a high diversity biological drug product.

Read the press release

To go further...

See Maat Pharma profil

Headlines

Our members

Tollys welcomes Dr. Jean-Pierre Armand as member of its scientific advisory board

March 9^th, 2021

Novadiscovery raises Series A2 financing from Sanofi to advance JINKO

February 16^th, 2021

DEINOVE benefits from the support of the French government, within the framework of the “France Relance” plan, to accelerate the development of new antimicrobials

March 11^th, 2021

All news